-
Medicine
-
Cardiac surgery
-
Human anatomy
-
Foot
-
Hospital
-
Tooth brushing
-
Rhytidectomy (Facelift)
-
Cryosurgery
-
Human skin
-
Health
-
International Classification of Diseases
-
Medical ultrasonography
-
Obstetrics
-
Doctor of Medicine
-
Scalpel
-
World Health Organization
-
Jet lag
-
Hypnosis
-
Nursing
-
Palliative care
-
British Medical Association
-
Trauma center
-
Emergency department
-
Hip replacement
-
Artificial skin
-
Sildenafil
-
Diabetes mellitus
-
Prognosis
-
Medicare (United States)
-
Heart
-
Phytotherapy
-
Acupuncture
-
Preventive medicine
-
Delirium tremens
-
Drug design
-
Bipolar disorder
-
Liver
-
Foodborne illness
-
Medical drama
-
Prosthesis
-
Eating disorder
-
Noble Prize in Physiology or Medicine
-
Mount Sinai Hospital
-
Epidemiology
-
Radiology
-
List of medical schools in the United Kingdom
-
Optometry
-
Tinnitus
-
Paramedic
-
Vital signs
|
Diabetes mellitus

Text is available under the
Creative Commons Attribution-ShareAlike License; additional
terms may apply. See
Terms of
Use for details.
Wikipedia® is a registered trademark of the
Wikimedia Foundation,
Inc., a non-profit organization.
Traduzione
interattiva on/off
- Togli il segno di spunta per disattivarla

Diabetes mellitus, or simply diabetes, is a group of
metabolic diseases in which a person has high
blood sugar, either because the
pancreas does not produce enough
insulin,
or because cells do not respond to the insulin that is produced.[2]
This high blood sugar produces the classical symptoms of
polyuria (frequent urination),
polydipsia (increased thirst) and
polyphagia (increased hunger).
There are three main types of diabetes mellitus (DM).
-
Type 1 DM results from the body's failure to produce insulin,
and currently requires the person to inject insulin or wear an
insulin pump. This form was previously referred to as
"insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes".
-
Type 2 DM results from
insulin resistance, a condition in which cells fail to use
insulin properly, sometimes combined with an absolute insulin
deficiency. This form was previously referred to as non
insulin-dependent diabetes mellitus (NIDDM) or "adult-onset
diabetes".
- The third main form,
gestational diabetes occurs when pregnant women without a
previous diagnosis of diabetes develop a high blood glucose level.
It may precede development of type 2 DM.
Other forms of diabetes mellitus include congenital diabetes, which
is due to
genetic
defects of insulin secretion,
cystic fibrosis-related diabetes, steroid diabetes induced by high
doses of glucocorticoids, and several forms of
monogenic diabetes.
Untreated, diabetes can cause many complications.
Acute complications include
diabetic ketoacidosis and
nonketotic hyperosmolar coma. Serious long-term complications
include
cardiovascular disease,
chronic renal failure, and
diabetic retinopathy (retinal damage). Adequate treatment of
diabetes is thus important, as well as
blood pressure control and lifestyle factors such as stopping
smoking and maintaining a healthy
body weight.
All forms of diabetes have been treatable since
insulin
became available in 1921, and type 2 diabetes may be controlled with
medications. Insulin and some oral medications can cause
hypoglycemia (low blood sugars), which can be dangerous if severe.
Both types 1 and 2 are
chronic conditions that cannot be cured.
Pancreas transplants have been tried with limited success in type 1
DM;
gastric bypass surgery has been successful in many with
morbid obesity and type 2 DM. Gestational diabetes usually resolves
after delivery.
Classification
Comparison of type 1 and 2 diabetes[3]
| Feature |
Type 1 diabetes |
Type 2 diabetes |
| Onset |
Sudden |
Gradual |
| Age at onset |
Mostly in children |
Mostly in adults |
| Body habitus |
Thin or normal[4] |
Often
obese |
|
Ketoacidosis |
Common |
Rare |
|
Autoantibodies |
Usually present |
Absent |
| Endogenous insulin |
Low or absent |
Normal, decreased
or increased |
Concordance
in
identical twins |
50% |
90% |
| Prevalence |
~10% |
~90% |
Diabetes mellitus is classified into four broad categories:
type 1,
type 2,
gestational diabetes and "other specific types".[2]
The "other specific types" are a collection of a few dozen individual
causes.[2]
The term "diabetes", without qualification, usually refers to diabetes
mellitus. The rare disease
diabetes insipidus has similar symptoms as diabetes mellitus, but
without disturbances in the sugar metabolism (insipidus means
"without taste" in Latin) and does not involve the same disease
mechanisms.
The term "type 1 diabetes" has replaced several former terms,
including childhood-onset diabetes, juvenile diabetes, and
insulin-dependent diabetes mellitus (IDDM). Likewise, the term "type 2
diabetes" has replaced several former terms, including adult-onset
diabetes, obesity-related diabetes, and noninsulin-dependent diabetes
mellitus (NIDDM). Beyond these two types, there is no agreed-upon
standard nomenclature.
Type 1 diabetes
Type 1 diabetes mellitus is characterized by loss of the
insulin-producing
beta
cells of the
islets of Langerhans in the pancreas, leading to insulin deficiency.
This type can be further classified as immune-mediated or idiopathic.
The majority of type 1 diabetes is of the immune-mediated nature, in
which beta cell loss is a
T-cell-mediated
autoimmune attack.[5]
There is no known preventive measure against type 1 diabetes, which
causes approximately 10% of diabetes mellitus cases in North America and
Europe. Most affected people are otherwise healthy and of a healthy
weight when onset occurs. Sensitivity and responsiveness to insulin are
usually normal, especially in the early stages. Type 1 diabetes can
affect children or adults, but was traditionally termed "juvenile
diabetes" because a majority of these diabetes cases were in children.
"Brittle" diabetes, also known as unstable diabetes or labile
diabetes, is a term that was traditionally used to describe to dramatic
and recurrent swings in
glucose
levels, often occurring for no apparent reason in
insulin-dependent
diabetes. This term, however, has no biologic basis and should not be
used.[6]
There are many reasons for type 1 diabetes to be accompanied by
irregular and unpredictable
hyperglycemias, frequently with
ketosis,
and sometimes serious
hypoglycemias, including an impaired counterregulatory response to
hypoglycemia, occult infection, gastroparesis (which leads to erratic
absorption of dietary carbohydrates), and endocrinopathies (e.g.,
Addison's disease).[6]
These phenomena are believed to occur no more frequently than in 1% to
2% of persons with type 1 diabetes.[7]
Type 2 diabetes
Type 2 diabetes mellitus is characterized by
insulin resistance, which may be combined with relatively reduced
insulin secretion.[2]
The defective responsiveness of body tissues to insulin is believed to
involve the
insulin receptor. However, the specific defects are not known.
Diabetes mellitus cases due to a known defect are classified separately.
Type 2 diabetes is the most common type.
In the early stage of type 2, the predominant abnormality is reduced
insulin sensitivity. At this stage, hyperglycemia can be reversed by a
variety of measures and
medications that improve insulin sensitivity or reduce glucose
production by the
liver.
Gestational
diabetes
Gestational diabetes mellitus (GDM) resembles type 2 diabetes in
several respects, involving a combination of relatively inadequate
insulin secretion and responsiveness. It occurs in about 2%–5% of all
pregnancies and may improve or disappear after delivery. Gestational
diabetes is fully treatable, but requires careful medical supervision
throughout the pregnancy. About 20%–50% of affected women develop type 2
diabetes later in life.
Though it may be transient, untreated gestational diabetes can damage
the health of the fetus or mother. Risks to the baby include
macrosomia (high birth weight), congenital cardiac and central
nervous system anomalies, and skeletal muscle malformations. Increased
fetal insulin may inhibit fetal
surfactant production and cause
respiratory distress syndrome.
Hyperbilirubinemia may result from red blood cell destruction. In
severe cases, perinatal death may occur, most commonly as a result of
poor placental perfusion due to vascular impairment.
Labor induction may be indicated with decreased placental function.
A
Caesarean section may be performed if there is marked fetal distress
or an increased risk of injury associated with
macrosomia, such as
shoulder dystocia.
A 2008 study completed in the U.S. found the number of American women
entering pregnancy with pre-existing diabetes is increasing. In fact,
the rate of diabetes in expectant mothers has more than doubled in the
past six years.[8]
This is particularly problematic as diabetes raises the risk of
complications during pregnancy, as well as increasing the potential for
the children of diabetic mothers to become diabetic in the future.
Other types
Prediabetes indicates a condition that occurs when a person's blood
glucose levels are higher than normal but not high enough for a
diagnosis of type 2 DM. Many people destined to develop type 2 DM spend
many years in a state of prediabetes which has been termed "America's
largest healthcare epidemic."[9]:10–11
Latent autoimmune diabetes of adults (LADA) is a condition in which
type 1 DM develops in adults. Adults with LADA are frequently initially
misdiagnosed as having type 2 DM, based on age rather than
etiology.
Some cases of diabetes are caused by the body's tissue receptors not
responding to insulin (even when insulin levels are normal, which is
what separates it from type 2 diabetes); this form is very uncommon.
Genetic mutations (autosomal
or
mitochondrial) can lead to defects in
beta
cell function. Abnormal insulin action may also have been
genetically determined in some cases. Any disease that causes extensive
damage to the
pancreas may lead to diabetes (for example,
chronic pancreatitis and
cystic fibrosis). Diseases associated with excessive secretion of
insulin-antagonistic
hormones
can cause diabetes (which is typically resolved once the hormone excess
is removed). Many drugs impair insulin secretion and some toxins damage
pancreatic beta cells. The
ICD-10 (1992) diagnostic entity, malnutrition-related diabetes
mellitus (MRDM or MMDM, ICD-10 code E12), was deprecated by the
World Health Organization when the current taxonomy was introduced
in 1999.[10]
Signs and symptoms
Overview of the most significant symptoms of diabetes
The classic symptoms of untreated diabetes are loss of weight,
polyuria (frequent urination),
polydipsia (increased thirst) and
polyphagia (increased hunger).[11]
Symptoms may develop rapidly (weeks or months) in type 1 diabetes, while
they usually develop much more slowly and may be subtle or absent in
type 2 diabetes.
Prolonged high blood glucose can cause glucose absorption in the lens
of the eye, which leads to changes in its shape, resulting in vision
changes. Blurred vision is a common complaint leading to a diabetes
diagnosis. A number of skin rashes that can occur in diabetes are
collectively known as
diabetic dermadromes.
Diabetic
emergencies
People (usually with type 1 diabetes) may also present with
diabetic ketoacidosis, a state of metabolic dysregulation
characterized by the smell of
acetone,
a rapid, deep breathing known as
Kussmaul breathing, nausea, vomiting and
abdominal pain, and altered states of consciousness.
A rare but equally severe possibility is
hyperosmolar nonketotic state, which is more common in type 2
diabetes and is mainly the result of dehydration.
Complications
All forms of diabetes increase the risk of long-term complications.
These typically develop after many years (10–20), but may be the first
symptom in those who have otherwise not received a diagnosis before that
time. The major long-term complications relate to damage to
blood vessels. Diabetes doubles the risk of
cardiovascular disease.[12]
The main
"macrovascular" diseases (related to
atherosclerosis of larger arteries) are
ischemic heart disease (angina
and
myocardial infarction),
stroke
and
peripheral vascular disease.
Diabetes also damages the
capillaries (causes
microangiopathy).[13]
Diabetic retinopathy, which affects blood vessel formation in the
retina
of the eye, can lead to visual symptoms including reduced vision and
potentially
blindness.
Diabetic nephropathy, the impact of diabetes on the kidneys, can
lead to
scarring changes in the kidney tissue, loss of
small or progressively
larger amounts of protein in the urine, and eventually
chronic kidney disease requiring
dialysis.
Another risk is
diabetic neuropathy, the impact of diabetes on the
nervous system — most commonly causing numbness, tingling and pain
in the feet, and also increasing the risk of skin damage due to altered
sensation. Together with vascular disease in the legs, neuropathy
contributes to the risk of
diabetes-related foot problems (such as
diabetic foot ulcers) that can be difficult to treat and
occasionally require
amputation. As well,
proximal diabetic neuropathy causes painful
muscle wasting and weakness.
Several studies suggest[14]
a link between
cognitive deficit and diabetes. Compared to those without diabetes,
the research showed that those with the disease have a 1.2 to 1.5-fold
greater rate of decline in cognitive function, and are at greater risk.
Causes
The cause of diabetes depends on the type.
Type 1 diabetes is partly inherited, and then triggered by certain
infections, with some evidence pointing at
Coxsackie B4 virus. A genetic element in individual susceptibility
to some of these triggers has been traced to particular
HLA
genotypes (i.e., the genetic "self" identifiers relied upon by the
immune system). However, even in those who have inherited the
susceptibility, type 1 DM seems to require an environmental trigger. The
onset of type 1 diabetes is unrelated to lifestyle.
Type 2 diabetes is due primarily to lifestyle factors and genetics.[15]
The following is a comprehensive list of other causes of diabetes:[16]
- Genetic defects of β-cell function
- Genetic defects in insulin processing or insulin action
- Defects in
proinsulin conversion
- Insulin gene mutations
- Insulin receptor mutations
- Exocrine pancreatic defects
|
|
Pathophysiology
The fluctuation of blood sugar (red) and the sugar-lowering
hormone
insulin (blue) in humans during the course of a day with
three meals - one of the effects of a
sugar-rich vs a
starch-rich meal is highlighted.
Mechanism of insulin release in normal pancreatic beta cells
- insulin production is more or less constant within the
beta cells. Its release is triggered by food, chiefly food
containing absorbable glucose.
Insulin is the principal hormone that regulates uptake of
glucose
from the blood into most cells (primarily muscle and fat cells, but not
central nervous system cells). Therefore, deficiency of insulin or the
insensitivity of its
receptors plays a central role in all forms of diabetes mellitus.
Humans are capable of digesting some
carbohydrates, in particular those most common in food; starch, and
some disaccharides such as sucrose, are converted within a few hours to
simpler forms, most notably the
monosaccharide
glucose,
the principal carbohydrate energy source used by the body. The rest are
passed on for processing by gut flora largely in the colon. Insulin is
released into the blood by beta cells (β-cells), found in the islets of
Langerhans in the pancreas, in response to rising levels of blood
glucose, typically after eating. Insulin is used by about two-thirds of
the body's cells to absorb glucose from the blood for use as fuel, for
conversion to other needed molecules, or for storage.
Insulin is also the principal control signal for conversion of
glucose to
glycogen for internal storage in liver and muscle cells. Lowered
glucose levels result both in the reduced release of insulin from the
β-cells and in the reverse conversion of glycogen to glucose when
glucose levels fall. This is mainly controlled by the hormone
glucagon, which acts in the opposite manner to insulin. Glucose thus
forcibly produced from internal liver cell stores (as glycogen)
re-enters the bloodstream; muscle cells lack the necessary export
mechanism. Normally, liver cells do this when the level of insulin is
low (which normally correlates with low levels of blood glucose).
Higher insulin levels increase some
anabolic ("building up") processes, such as cell growth and
duplication,
protein synthesis, and
fat
storage. Insulin (or its lack) is the principal signal in converting
many of the bidirectional processes of metabolism from a
catabolic to an anabolic direction, and vice versa. In
particular, a low insulin level is the trigger for entering or leaving
ketosis (the fat-burning metabolic phase).
If the amount of insulin available is insufficient, if cells respond
poorly to the effects of insulin (insulin insensitivity or resistance),
or if the insulin itself is defective, then glucose will not have its
usual effect, so it will not be absorbed properly by those body cells
that require it, nor will it be stored appropriately in the liver and
muscles. The net effect is persistent high levels of blood glucose, poor
protein synthesis, and other metabolic derangements, such as
acidosis.
When the glucose concentration in the blood is raised to about
9-10 mmol/L (except certain conditions, such as pregnancy), beyond its
renal threshold (i.e. when glucose level surpasses the
transport maximum of glucose reabsorption),
reabsorption of glucose in the
proximal renal tubuli is incomplete, and part of the glucose remains
in the urine
(glycosuria).
This increases the
osmotic pressure of the urine and inhibits reabsorption of water by
the kidney, resulting in increased urine production (polyuria)
and increased fluid loss. Lost blood volume will be replaced osmotically
from water held in body cells and other body compartments, causing
dehydration and increased thirst.
Diagnosis
Diabetes diagnostic criteria[18][19]
edit
| Condition |
2 hour glucose |
Fasting glucose |
HbA1c |
| |
mmol/l(mg/dl) |
mmol/l(mg/dl) |
% |
| Normal |
<7.8 (<140) |
<6.1 (<110) |
<6.0 |
|
Impaired fasting glycaemia |
<7.8 (<140) |
≥ 6.1(≥110) & <7.0(<126) |
6.0–6.4 |
|
Impaired glucose tolerance |
≥7.8 (≥140) |
<7.0 (<126) |
6.0–6.4 |
| Diabetes mellitus |
≥11.1 (≥200) |
≥7.0 (≥126) |
≥6.5 |
Diabetes mellitus is characterized by recurrent or persistent
hyperglycemia, and is diagnosed by demonstrating any one of the
following:[10]
A positive result, in the absence of unequivocal hyperglycemia,
should be confirmed by a repeat of any of the above methods on a
different day. It is preferable to measure a fasting glucose level
because of the ease of measurement and the considerable time commitment
of formal glucose tolerance testing, which takes two hours to complete
and offers no prognostic advantage over the fasting test.[21]
According to the current definition, two fasting glucose measurements
above 126 mg/dl (7.0 mmol/l) is considered diagnostic for diabetes
mellitus.
People with fasting glucose levels from 110 to 125 mg/dl (6.1 to
6.9 mmol/l) are considered to have
impaired fasting glucose.[22]
Patients with plasma glucose at or above 140 mg/dL (7.8 mmol/L), but not
over 200 mg/dL (11.1 mmol/L), two hours after a 75 g oral glucose load
are considered to have
impaired glucose tolerance. Of these two prediabetic states, the
latter in particular is a major risk factor for progression to
full-blown diabetes mellitus, as well as cardiovascular disease.[23]
Glycated hemoglobin is better than
fasting glucose for determining risks of cardiovascular disease and
death from any cause.[24]
Management
Diabetes mellitus is a
chronic disease, for which there is no known cure except in very
specific situations. Management concentrates on keeping blood sugar
levels as close to normal ("euglycemia") as possible, without causing
hypoglycemia. This can usually be accomplished with diet, exercise, and
use of appropriate medications (insulin in the case of type 1 diabetes;
oral medications, as well as possibly insulin, in type 2 diabetes).
Patient education, understanding, and participation is vital, since
the complications of diabetes are far less common and less severe in
people who have well-managed blood sugar levels.[25][26]
The goal of treatment is an HbA1C level of 6.5%, but should not be lower
than that, and may be set higher.[27]
Attention is also paid to other health problems that may accelerate the
deleterious effects of diabetes. These include
smoking,
elevated cholesterol levels,
obesity,
high blood pressure, and lack of regular
exercise.[27]
Specialised footwear is widely used to reduce the risk of
ulceration, or re-ulceration, in at-risk diabetic feet. Evidence for the
efficacy of this remains equivocal, however.[28]
Lifestyle
There are roles for patient education, dietetic support, sensible
exercise, with the goal of keeping both short-term and long-term blood
glucose levels
within acceptable bounds. In addition, given the associated higher
risks of cardiovascular disease, lifestyle modifications are recommended
to control blood pressure.[29]
Medications
Metformin is generally recommended as a first line treatment for
type 2 diabetes, as there is good evidence that it decreases mortality.[30]
Routine use of
aspirin,
however, has not been found to improve outcomes in uncomplicated
diabetes.[31]
Type 1 diabetes is typically treated with a combinations of regular
and NPH
insulin, or synthetic
insulin analogs. When insulin is used in type 2 diabetes, a
long-acting formulation is usually added initially, while continuing
oral medications.[30]
Doses of insulin are then increased to effect.[30]
Support
In countries using a
general practitioner system, such as the
United Kingdom, care may take place mainly outside hospitals, with
hospital-based specialist care used only in case of complications,
difficult blood sugar control, or research projects. In other
circumstances, general practitioners and specialists share care of a
patient in a team approach. Home
telehealth support can be an effective management technique.[32]
Epidemiology
Prevalence of diabetes worldwide in 2000 (per 1,000
inhabitants) - world average was 2.8%.
no data
≤ 7.5
7.5–15
15–22.5
22.5–30
30–37.5
37.5–45
|
45–52.5
52.5–60
60–67.5
67.5–75
75–82.5
≥ 82.5
|
Disability-adjusted life year for diabetes mellitus per
100,000 inhabitants in 2004
No data
<100
100–200
200–300
300–400
400–500
500–600
|
600–700
700–800
800–900
900–1,000
1,000–1,500
>1,500
|
Globally, as of 2010, an estimated 285 million people had diabetes,
with type 2 making up about 90% of the cases.[3]
Its incidence is increasing rapidly, and by 2030, this number is
estimated to almost double.[33]
Diabetes mellitus occurs throughout the world, but is more common
(especially type 2) in the more developed countries. The greatest
increase in prevalence is, however, expected to occur in Asia and
Africa, where most patients will probably be found by 2030.[33]
The increase in incidence in developing countries follows the trend of
urbanization and lifestyle changes, perhaps most importantly a
"Western-style" diet. This has suggested an environmental (i.e.,
dietary) effect, but there is little understanding of the mechanism(s)
at present, though there is much speculation, some of it most
compellingly presented.[33]
History
Diabetes was one of the first diseases described,[34]
with an Egyptian manuscript from
c. 1500
BCE
mentioning "too great emptying of the urine".[35]
The first described cases are believed to be of type 1 diabetes.[35]
Indian physicians around the same time identified the disease and
classified it as madhumeha or "honey urine", noting the urine
would attract ants.[35]
The term "diabetes" or "to pass through" was first used in 230 BCE by
the Greek
Appollonius of Memphis.[35]
The disease was considered as rare during the time of the
Roman empire, with
Galen
commenting he had only seen two cases during his career.[35]
This is possibly due the diet and life-style of the ancient people, or
because the clinical symptoms were observed during the advanced stage of
the disease. Galen named the disease "diarrhea of the urine" (diarrhea
urinosa). The earliest surviving work with a detailed reference to
diabetes is that of
Aretaeus of Cappadocia (2nd or early 3rd century CE). He described
the symptoms and the course of the disease, which he attributed to the
moisture and coldness, reflecting the beliefs of the "Pneumatic School".
He hypothesized a correlation of diabetes with other diseases and he
discussed differential diagnosis from the snakebite which also provokes
excessive thirst. His work remained unknown in the West until the middle
of the 16th century when, in 1552, the first Latin edition was published
in Venice.[36]
Type 1 and type 2 diabetes where identified as separate conditions
for the first time by the Indian physicians Sushruta and Charaka in
400-500 CE with type 1 associated with youth and type 2 with being
overweight.[35]
The term "mellitus" or "from honey" was added by the Briton John Rolle
in the late 1700s to separate the condition from
diabetes insipidus, which is also associated with frequent
urination.[35]
Effective treatment was not developed until the early part of the 20th
century, when Canadians
Frederick Banting and
Charles Herbert Best isolated and purified insulin in 1921 and 1922.[35]
This was followed by the development of the long-acting insulin NPH in
the 1940s.[35]
Etymology
The word diabetes (/ˌdaɪ.əˈbiːtiːz/
or
/ˌdaɪ.əˈbiːtɨs/)
comes from
Latin diabētēs, which in turn comes from
Ancient Greek διαβήτης (diabētēs) which literally means "a
passer through; a
siphon."[37]
Ancient Greek
physician
Aretaeus of Cappadocia (fl.
1st century
CE)
used that word, with the intended meaning "excessive discharge of
urine", as the name for the disease.[38][39]
Ultimately, the word comes from Greek διαβαίνειν (diabainein),
meaning "to pass through,"[37]
which is composed of δια- (dia-), meaning "through" and βαίνειν (bainein),
meaning "to go".[38]
The word "diabetes" is first recorded in English, in the form diabete,
in a medical text written around 1425.
The word
mellitus (/mɨˈlaɪtəs/
or
/ˈmɛlɨtəs/)
comes from the classical Latin word mellītus, meaning "mellite"[40]
(i.e. sweetened with honey;[40]
honey-sweet[41]).
The Latin word comes from mell-, which comes from mel,
meaning "honey";[40][41]
sweetness;[41]
pleasant thing,[41]
and the suffix -ītus,[40]
whose meaning is the same as that of the English suffix "-ite".[42]
It was
Thomas Willis who in 1675 added "mellitus" to the word "diabetes" as
a designation for the disease, when he noticed the urine of a diabetic
had a sweet taste (glycosuria).[39]
This sweet taste had been noticed in urine by the ancient Greeks,
Chinese, Egyptians, Indians, and Persians.
Society and
culture
The 1989 "St.
Vincent Declaration"[43][44]
was the result of international efforts to improve the care accorded to
those with diabetes. Doing so is important not only in terms of quality
of life and life expectancy, but also economically—expenses due to
diabetes have been shown to be a major drain on health—and
productivity-related resources for healthcare systems and governments.
Several countries established more and less successful national
diabetes programmes to improve treatment of the disease.[45]
Diabetic patients with neuropathic symptoms such as
numbness or tingling in feet or hands are twice as likely to be
unemployed as those without the symptoms.[46]
Other animals
In animals, diabetes is most commonly encountered in dogs and cats.
Middle-aged animals are most commonly affected. Female dogs are twice as
likely to be affected as males, while according to some sources, male
cats are also more prone than females. In both species, all breeds may
be affected, but some small dog breeds are particularly likely to
develop diabetes, such as
Miniature
Poodles.[47]
The symptoms may relate to fluid loss and polyuria, but the course may
also be insidious. Diabetic animals are more prone to infections. The
long-term complications recognised in humans are much rarer in animals.
The principles of treatment (weight loss, oral antidiabetics,
subcutaneous insulin) and management of emergencies (e.g. ketoacidosis)
are similar to those in humans.[47]
References
-
^
"Diabetes Blue Circle Symbol". International Diabetes
Federation. 17 March 2006.
- ^
a
b
c
d
Shoback, edited by David G. Gardner, Dolores (2011).
Greenspan's basic & clinical endocrinology (9th ed.). New
York: McGraw-Hill Medical. pp. Chapter 17.
ISBN 0-07-162243-8.
- ^
a
b
Williams textbook of endocrinology (12th ed.). Philadelphia:
Elsevier/Saunders. pp. 1371–1435.
ISBN 978-1-4377-0324-5.
-
^
Lambert, P.; Bingley, P. J.
(2002). "What is Type 1 Diabetes?". Medicine 30:
1–5.
doi:10.1383/medc.30.1.1.28264.
Diabetes Symptoms
edit
-
^
Rother KI (April 2007). "Diabetes
treatment—bridging the divide". The New England Journal of
Medicine 356 (15): 1499–501.
doi:10.1056/NEJMp078030.
PMID 17429082.
- ^
a
b
"Diabetes Mellitus (DM): Diabetes Mellitus and Disorders of
Carbohydrate Metabolism: Merck Manual Professional".
Merck Publishing. April 2010.
Retrieved 2010-07-30.
-
^
Dorner M, Pinget M, Brogard JM
(May 1977). "Essential labile diabetes". MMW Munch Med
Wochenschr (in German) 119 (19): 671–4.
PMID 406527.
-
^
Lawrence JM, Contreras R, Chen W,
Sacks DA (May 2008). "Trends in the prevalence of preexisting
diabetes and gestational diabetes mellitus among a
racially/ethnically diverse population of pregnant women,
1999–2005". Diabetes Care 31 (5): 899–904.
doi:10.2337/dc07-2345.
PMID 18223030.
-
^
Handelsman Y, MD. "A Doctor's
Diagnosis: Prediabetes". Power of Prevention 1
(2).
-
^
a
b
"Definition, Diagnosis and Classification of Diabetes Mellitus
and its Complications" (PDF).
World Health Organisation. 1999.
-
^
Cooke DW, Plotnick L (November
2008). "Type 1 diabetes mellitus in pediatrics". Pediatr Rev
29 (11): 374–84; quiz 385.
doi:10.1542/pir.29-11-374.
PMID 18977856.
-
^
Emerging Risk Factors
Collaboration (2010).
"Diabetes mellitus, fasting blood glucose concentration, and
risk of vascular disease: A collaborative meta-analysis of 102
prospective studies". The Lancet 375 (9733):
2215–22.
doi:10.1016/S0140-6736(10)60484-9.
PMC 2904878.
PMID 20609967.
-
^
Boussageon R, Bejan-Angoulvant T,
Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B,
Erpeldinger S, Wright JM, Gueyffier F, Cornu C (2011).
"Effect of intensive glucose lowering treatment on all cause
mortality, cardiovascular death, and microvascular events in
type 2 diabetes: meta-analysis of randomised controlled trials".
BMJ
343: d4169.
doi:10.1136/bmj.d4169.
PMC 3144314.
PMID 21791495.
-
^
Cukierman, T (8 Nov 2005).
"Cognitive decline and dementia in diabetes—systematic overview
of prospective observational studies". Springer-Verlag.
Retrieved 28 Apr 2013.
-
^
Risérus U,
Willet W (January 2009).
"Dietary fats and prevention of type 2 diabetes".
Progress in Lipid Research 48 (1): 44–51.
doi:10.1016/j.plipres.2008.10.002.
PMC 2654180.
PMID 19032965.
-
^ Unless otherwise
specified, reference is: Table 20-5 in
Mitchell, Richard Sheppard; Kumar,
Vinay; Abbas, Abul K.; Fausto, Nelson. Robbins Basic
Pathology. Philadelphia: Saunders.
ISBN 1-4160-2973-7.
8th edition.
-
^
Sattar N, Preiss, D, Murray, HM,
Welsh, P, Buckley, BM, de Craen, AJ, Seshasai, SR, McMurray, JJ,
Freeman, DJ (February 2010). "Statins and risk of incident
diabetes: a collaborative meta-analysis of randomised statin
trials". The Lancet 375 (9716): 735–42.
doi:10.1016/S0140-6736(09)61965-6.
PMID 20167359.
-
^
Definition and diagnosis of diabetes mellitus and
intermediate hyperglycemia: report of a WHO/IDF consultation.
Geneva:
World Health Organization. 2006. p. 21.
ISBN 978-92-4-159493-6.
-
^
Vijan, S (March 2010). "Type 2
diabetes".
Annals of Internal Medicine 152 (5): ITC31-15.
doi:10.1059/0003-4819-152-5-201003020-01003.
PMID 20194231.
-
^
""Diabetes Care" January 2010".
American Diabetes Association.
Retrieved 2010-01-29.
-
^
Saydah SH, Miret M, Sung J, Varas
C, Gause D, Brancati FL (August 2001). "Postchallenge
hyperglycemia and mortality in a national sample of U.S.
adults". Diabetes Care 24 (8): 1397–402.
doi:10.2337/diacare.24.8.1397.
PMID 11473076.
-
^
Definition and diagnosis of diabetes mellitus and
intermediate hyperglycemia : report of a WHO/IDF consultation.
World Health Organization. 2006. p. 21.
ISBN 978-92-4-159493-6.
-
^
Santaguida PL, Balion C, Hunt D,
Morrison K, Gerstein H, Raina P, Booker L, Yazdi H.
"Diagnosis, Prognosis, and Treatment of Impaired Glucose
Tolerance and Impaired Fasting Glucose". Summary of
Evidence Report/Technology Assessment, No. 128.
Agency for Healthcare Research and Quality.
Retrieved 2008-07-20.
-
^
Selvin E, Steffes MW, Zhu H,
Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL
(2010).
"Glycated hemoglobin, diabetes, and cardiovascular risk in
nondiabetic adults". N. Engl. J. Med. 362 (9):
800–11.
doi:10.1056/NEJMoa0908359.
PMC 2872990.
PMID 20200384.
-
^
Nathan DM, Cleary PA, Backlund
JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B;
Diabetes Control and Complications Trial/Epidemiology of
Diabetes Interventions and Complications (DCCT/EDIC) Study
Research Group (December 2005).
"Intensive diabetes treatment and cardiovascular disease in
patients with type 1 diabetes". The New England Journal
of Medicine 353 (25): 2643–53.
doi:10.1056/NEJMoa052187.
PMC 2637991.
PMID 16371630.
-
^
<Please add first missing authors
to populate metadata.> (April 1995). "The effect of intensive
diabetes therapy on the development and progression of
neuropathy. The Diabetes Control and Complications Trial
Research Group". Annals of Internal Medicine 122
(8): 561–8.
doi:10.1059/0003-4819-122-8-199504150-00001.
PMID 7887548.
- ^
a
b
National Institute for Health and Clinical Excellence.
Clinical guideline 66: Type 2 diabetes. London, 2008.
-
^
Cavanagh, P. R. (2004).
"Therapeutic footwear for people with diabetes".
Diabetes/Metabolism Research and Reviews 20: S51–S55.
doi:10.1002/dmrr.435.
edit
-
^
Adler AI, Stratton IM, Neil HA,
Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR
(August 2000).
"Association of systolic blood pressure with macrovascular and
microvascular complications of type 2 diabetes (UKPDS 36):
prospective observational study". BMJ 321
(7258): 412–9.
doi:10.1136/bmj.321.7258.412.
PMC 27455.
PMID 10938049.
- ^
a
b
c
Ripsin CM, Kang, H, Urban, RJ (2009).
"Management of blood glucose in type 2 diabetes mellitus".
American family physician 79 (1): 29–36.
PMID 19145963.
-
^
Pignone M, Alberts MJ, Colwell
JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams
CD, Wilson PW, Kirkman MS; American Diabetes Association;
American Heart Association; American College of Cardiology
Foundation (June 2010).
"Aspirin for primary prevention of cardiovascular events in
people with diabetes: a position statement of the American
Diabetes Association, a scientific statement of the American
Heart Association, and an expert consensus document of the
American College of Cardiology Foundation". Diabetes Care
33 (6): 1395–402.
doi:10.2337/dc10-0555.
PMC 2875463.
PMID 20508233.
-
^
Polisena J, Tran K, Cimon K,
Hutton B, McGill S, Palmer K (2009). "Home telehealth for
diabetes management: a systematic review and meta-analysis".
Diabetes Obes Metab 11 (10): 913–30.
doi:10.1111/j.1463-1326.2009.01057.x.
PMID 19531058.
- ^
a
b
c
Wild
S, Roglic G, Green A, Sicree R, King H (2004). "Global
prevalence of diabetes: Estimates for the year 2000 and
projections for 2030". Diabetes Care 27 (5):
1047–53.
doi:10.2337/diacare.27.5.1047.
PMID 15111519.
-
^
Ripoll, Brian C. Leutholtz, Ignacio
(2011-04-25).
Exercise and disease management (2nd ed.). Boca
Raton: CRC Press. p. 25.
ISBN 978-1-4398-2759-8.
-
^
a
b
c
d
e
f
g
h
i
editor,
Leonid Poretsky, (2009).
Principles of diabetes mellitus (2nd ed.). New York:
Springer. p. 3.
ISBN 978-0-387-09840-1.
-
^
Konstantinos Laios et al.
(2012). "Aretaeus of Cappadocia and the first description of
diabetes". Hormones 11 (1): 109–113.
-
^
a
b
Oxford English Dictionary.
diabetes. Retrieved 2011-06-10.
-
^
a
b
Harper,
Douglas (2001–2010).
"Online Etymology Dictionary. diabetes.".
Retrieved 2011-06-10.
- ^
a
b
Dallas,
John (2011).
"Royal College of Physicians of Edinburgh. Diabetes, Doctors and
Dogs: An exhibition on Diabetes and Endocrinology by the College
Library for the 43rd St. Andrew's Day Festival Symposium".
-
^
a
b
c
d
Oxford English Dictionary.
mellite. Retrieved 2011-06-10.
-
^
a
b
c
d
"MyEtimology. mellitus.".
Retrieved 2011-06-10.
-
^ Oxford English
Dictionary. -ite. Retrieved 2011-06-10.
-
^
Theodore H. Tulchinsky, Elena A.
Varavikova (2008). The New Public Health, Second Edition.
New York:
Academic Press. p. 200.
ISBN 0-12-370890-7.
-
^
Piwernetz K, Home PD, Snorgaard
O, Antsiferov M, Staehr-Johansen K, Krans M (May 1993).
"Monitoring the targets of the St Vincent Declaration and the
implementation of quality management in diabetes care: the
DIABCARE initiative. The DIABCARE Monitoring Group of the St
Vincent Declaration Steering Committee". Diabetic Medicine
10 (4): 371–7.
doi:10.1111/j.1464-5491.1993.tb00083.x.
PMID 8508624.
-
^
Dubois, HFW and Bankauskaite, V
(2005).
"Type 2 diabetes programmes in Europe" (PDF). Euro
Observer 7 (2): 5–6.
-
^
Stewart WF, Ricci JA, Chee E,
Hirsch AG, Brandenburg NA (June 2007). "Lost productive time and
costs due to diabetes and diabetic neuropathic pain in the US
workforce". J. Occup. Environ. Med. 49 (6): 672–9.
doi:10.1097/JOM.0b013e318065b83a.
PMID 17563611.
- ^
a
b
"Diabetes mellitus". Merck Veterinary Manual, 9th edition
(online version). 2005.
Retrieved 2011-10-23.
Further reading
External links

|
blog comments powered by
|
|
DA INGLESE A ITALIANO
Inserire
nella casella Traduci la parola
INGLESE e cliccare
Go.
DA ITALIANO A INGLESE
Impostare INGLESE anziché italiano e
ripetere la procedura descritta.
|
Acupuncture
Artificial skin
Bipolar disorder
British Medical Association
Cardiac surgery
Cryosurgery
Delirium tremens
Diabetes mellitus
Doctor of Medicine
Drug design
Eating disorder
Emergency department
Epidemiology
Foodborne illness
Foot
Health
Heart
Hip replacement
Hospital
Human anatomy
Human skin
Hypnosis
International Classification of Diseases
Jet lag
List of medical schools in the United Kingdom
Liver
Medical drama
Medical ultrasonography
Medicare (United States)
Medicine
Mount Sinai Hospital
Noble Prize in Physiology or Medicine
Nursing
Obstetrics
Optometry
Palliative care
Paramedic
Phytotherapy
Preventive medicine
Prognosis
Prosthesis
Radiology
Rhytidectomy (Facelift)
Scalpel
Sildenafil
Tinnitus
Tooth brushing
Trauma center
Vital signs
World Health Organization
|